Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century (Q46989685)

27 December 2017

title

Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century (English)

1 reference

27 December 2017

main subject

cervix uterine cancer

1 reference

Lynette Denny

1

1 reference

27 December 2017

publication date

11 August 2012

1 reference

27 December 2017

International Journal of Gynecology and Obstetrics

published in

1 reference

27 December 2017

volume

119 Suppl 1

1 reference

27 December 2017

page(s)

S80-4

1 reference

27 December 2017

Worldwide burden of cervical cancer in 2008.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Cancer survival in Africa, Asia, and Central America: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Estimates of health care professional shortages in sub-Saharan Africa by 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Accuracy of visual inspection with acetic acid for cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

HPV screening for cervical cancer in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2012.03.023

10.1016/J.IJGO.2012.03.023

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017